Wells Fargo
ACLX

Wells Fargo’s Arcellx ACLX Stock Holding History

Wells Fargo’s Portfolio ACLX Stock Details ACLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.65M Sell
14,393
-39,867
-73% -$3.52M ﹤0.01% 3410
2025
Q4 		$3.54M Buy
54,260
+19,834
+58% +$1.58M ﹤0.01% 2986
2025
Q3 		$2.83M Buy
34,426
+3,837
+13% +$276K ﹤0.01% 3069
2025
Q2 		$2.01M Buy
30,589
+3,755
+14% +$234K ﹤0.01% 3211
2025
Q1 		$1.76M Buy
26,834
+196
+0.7% +$13.3K ﹤0.01% 3262
2024
Q4 		$2.04M Buy
26,638
+7,002
+36% +$605K ﹤0.01% 3185
2024
Q3 		$1.64M Sell
19,636
-359
-2% -$23.9K ﹤0.01% 3191
2024
Q2 		$1.1M Buy
19,995
+2,161
+12% +$117K ﹤0.01% 3422
2024
Q1 		$1.24M Buy
17,834
+7,319
+70% +$464K ﹤0.01% 3317
2023
Q4 		$584K Sell
10,515
-26,144
-71% -$1.18M ﹤0.01% 3764
2023
Q3 		$1.32M Sell
36,659
-3,867
-10% -$133K ﹤0.01% 3129
2023
Q2 		$1.28M Buy
40,526
+7,730
+24% +$296K ﹤0.01% 3274
2023
Q1 		$1.01M Buy
32,796
+30,136
+1,133% +$914K ﹤0.01% 3370
2022
Q4 		$82.4K Buy
2,660
+618
+30% +$14.2K ﹤0.01% 4630
2022
Q3 		$38K Buy
2,042
+1,923
+1,616% +$36.8K ﹤0.01% 5074
2022
Q2 		$2K Sell
119
-1,862
-94% -$24K ﹤0.01% 6280
2022
Q1 		$28K Buy
+1,981
New +$33.1K ﹤0.01% 5888

Other funds holding ACLX

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

Wells Fargo's ACLX Position: Q1 2026 in Review

Wells Fargo reduced its Arcellx (ACLX) stake by 73% in Q1 2026, selling an estimated $3.52M and leaving 14,393 shares worth $1.65M. The position accounts for ﹤0.01% of the portfolio, ranked #3410.

Wells Fargo first reported a position in ACLX in Q1 2022 and has held it in 17 quarters since. The position peaked at $3.54M in Q4 2025. 239 funds tracked by Wall St. Rank hold ACLX as of Q1 2026.

  • Wells Fargo held 14,393 shares of Arcellx worth $1.65M as of Q1 2026.
  • Wells Fargo sold 39,867 Arcellx shares in Q1 2026, an estimated $3.52M.
  • Arcellx made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #3410 holding.
  • Wells Fargo first reported a position in Arcellx in Q1 2022 and has held it in 17 quarters since.
  • Wells Fargo's Arcellx position peaked at $3.54M in Q4 2025.
  • 239 funds tracked by Wall St. Rank held Arcellx as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.